NDC 50090-3208-02 - Citalopram Hydrobromide

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 50090-3208
Requested NDC: 50090-3208-02
Package NDCs from labels: 50090-3208-1, 50090-3208-2, 50090-3208-0, 50090-3208-02
Manufacturer: A-S Medication Solutions
Effective date: 2024-09-18
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Citalopram Hydrobromide - A-S Medication Solutions	A-S Medication Solutions	2024-09-18	HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
50090-3208-0	2023-02-07	These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998
50090-3208-1	2023-02-07	These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998
50090-3208-2	2023-02-07	These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998
50090-3208-0	2023-01-30	These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998
50090-3208-1	2023-01-30	These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998
50090-3208-2	2023-01-30	These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50090-3208-0	Citalopram Hydrobromide	30 in 1 BOTTLE	TABLET	30	32
50090-3208-1	Citalopram Hydrobromide	100 in 1 BOTTLE	TABLET	100	32
50090-3208-2	Citalopram Hydrobromide	90 in 1 BOTTLE	TABLET	90	32

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-3208	CITALOPRAM HYDROBROMIDE TABLET [A-S MEDICATION SOLUTIONS]	32	Current NDC, Legacy NDC, 3 package rows	20240926_05421bee-f746-418e-bb9c-ab44a89b567d.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-3208-0	EA - Each	50090-3208	05469346-320e-4310-8f69-4a480059f65a	1	2018-12-13
50090-3208-1	EA - Each	50090-3208	4fae9114-9077-40af-b1cc-ccebecd7aa24	1	2018-12-13
50090-3208-2	EA - Each	50090-3208	1be49507-98a5-4fdd-a532-618a28a11709	1	2018-12-13

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 5 · 89 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Citalopram	CITALOPRAM HYDROBROMIDE	REMEDYREPACK INC.	0109f365-bebd-4810-a56f-4451e10245db	2026-09-04	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 309314 unii: I1E9D14F36
Citalopram	CITALOPRAM HYDROBROMIDE	REMEDYREPACK INC.	625a78b2-4751-4ca5-91b6-7c85fd9f8c2e	2026-08-27	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 200371 unii: I1E9D14F36
Citalopram	CITALOPRAM	REMEDYREPACK INC.	f79f878e-99fb-4757-8abb-931af1fa9e2b	2026-07-27	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 283672 unii: I1E9D14F36
Citalopram	CITALOPRAM	REMEDYREPACK INC.	aa9c1440-354f-43a6-9e70-fd7bafcb03c5	2026-07-27	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 309314 unii: I1E9D14F36
Citalopram	CITALOPRAM	REMEDYREPACK INC.	c9809dfe-939e-4f9d-b6dd-f9808fd9f2b1	2026-07-21	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 309314 unii: I1E9D14F36
Citalopram	CITALOPRAM	REMEDYREPACK INC.	25b0d184-2a4c-42b0-9a57-7a00fa3e0cd7	2026-07-15	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 200371 unii: I1E9D14F36
Citalopram	CITALOPRAM	PD-Rx Pharmaceuticals, Inc.	9fe40d83-8945-4577-add5-28d52410154e	2026-07-07	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 309314 unii: I1E9D14F36
Citalopram	CITALOPRAM	St. Mary's Medical Park Pharmacy	db900453-4777-4142-a236-5d3a6152d0a5	2026-06-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 200371 unii: I1E9D14F36
Citalopram	CITALOPRAM	Coupler LLC	53e5d66f-7902-76ac-e063-6294a90aa526	2026-06-10	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 283672 unii: I1E9D14F36
Citalopram	CITALOPRAM	Coupler LLC	53e6d0a4-95d9-9c1a-e063-6294a90a9d18	2026-06-10	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 309314 unii: I1E9D14F36
Citalopram	CITALOPRAM	Bryant Ranch Prepack	9b53c14c-224c-49ed-8a00-96f871593ab0	2026-06-04	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 283672 unii: I1E9D14F36
Citalopram	CITALOPRAM	ASCLEMED USA INC.	df8db06a-ced7-4dd6-83bd-c61d2f68f1b1	2026-05-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 283672 rxcui: 200371 rxcui: 309314 unii: I1E9D14F36
Citalopram	CITALOPRAM	St. Mary's Medical Park Pharmacy	351ca54b-0eb6-4e93-8ab4-82fb18dcc9e1	2026-05-22	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 283672 unii: I1E9D14F36
Citalopram	CITALOPRAM	QPharma, Inc.	f35bfd9e-afb6-409d-a804-6073d812609d	2026-05-08	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 200371 unii: I1E9D14F36
Citalopram	CITALOPRAM	PD-Rx Pharmaceuticals, Inc.	43785b49-5d1e-4ae9-b2ff-26be910bde7f	2026-05-05	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 200371 unii: I1E9D14F36
Citalopram	CITALOPRAM	REMEDYREPACK INC.	a26772e7-6e4d-489b-bb5e-5bc322ef6dfe	2026-05-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 283672 unii: I1E9D14F36
Citalopram	CITALOPRAM	PD-Rx Pharmaceuticals, Inc.	df929b3f-0cda-4a75-96d3-22e6b0edbbc9	2026-04-29	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 283672 unii: I1E9D14F36
Citalopram	CITALOPRAM	REMEDYREPACK INC.	bdc0c228-797a-42dd-8114-aa68c1eb3300	2026-04-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 200371 unii: I1E9D14F36
Citalopram	CITALOPRAM	Coupler LLC	50380ce5-c77f-3ee3-e063-6394a90a17ae	2026-04-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 200371 unii: I1E9D14F36
Citalopram	CITALOPRAM	Cardinal Health 107, LLC	6c8942f8-963a-4007-a147-b77ac629e4d4	2026-04-17	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA078216 rxcui: 283672 rxcui: 200371 unii: I1E9D14F36

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.